Acrylic lenses produce virtually no PCO

Article

The new acrylic *Acri.Lyc 356 (*Acri.Tec) diffractive intraocular lens (IOL) produces practically no posterior capsule opacification (PCO) compared with its silicone counterpart.

The new acrylic *Acri.Lyc 356 (*Acri.Tec) diffractive intraocular lens (IOL) produces practically no posterior capsule opacification (PCO) compared with its silicone counterpart, according to Filippo Simona from the LaserVis Refractive Centre, Locarno, Switzerland.

In a prospective, non-randomized pilot study, 116 eyes of 78 patients with senile cataract underwent phacoemulsification and implantation of the acylic *Acri.Lyc 356 (35 eyes) or the silicone *Acri.Tec 737 (81 eyes).

The results showed that both lenses provided both good near and distance visual acuity, however, the acrylic lens produced hardly any PCO, just 1% compared with 14% in the silicone group.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.